Tenofovir disoproxil fumarate reduces hepatocellular carcinoma, decompensation and death in chronic hepatitis B patients with cirrhosis.
Ken LiuJonggi ChoiAn LeTerry Cheuk-Fung YipVincent Wai-Sun WongStephen Lam ChanHenry Lik Yuen ChanMindie H NguyenYoung Suk LimGrace Lai-Hung WongPublished in: Alimentary pharmacology & therapeutics (2019)
Compared to untreated patients, TDF treatment reduces the risks of HCC, hepatic decompensation and death in CHB patients with cirrhosis at 5 years.